Beckley Science in the Media

Thumbnail image for New study from Beckley collaboration supports therapeutic potential of Ayahuasca by showing increased mindfulness

New study from Beckley collaboration supports therapeutic potential of Ayahuasca by showing increased mindfulness

November 30, 2015 Beckley in the Media

Beckley Foundation collaborator Jordi Riba and his team at Sant Pau Hospital in Barcelona have just published a study in the journal Psychopharmacology, co-authored by the Beckley’s Executive Director, Amanda Feilding, which shows that one of the ways ayahuasca achieves its reported therapeutic effects is by increasing people’s capacity for mindfulness – the same capacity […]

Continue Reading →
Thumbnail image for Psychedelic Science Conference 2013

Psychedelic Science Conference 2013

April 26, 2013 Beckley in the Media

The Psychedelic Science conference, co-hosted by the Beckley Foundation, brought together researchers from around the world to discuss research, clinical trials, and medical discoveries involving psychedelic substances. Amanda Feilding presented the results of the Beckley Foundation research programme, including our recent investigations into psilocybin and MDMA.

Continue Reading →
http://www.beckleyfoundation.org/wp-content/uploads/2013/05/mdma-pills.png

MDMA may help treat depression and PTSD, Channel 4 study suggests

September 28, 2012 Beckley in the Media

Research hints at therapeutic uses for MDMA – but the taboo surrounding psychoactive drugs prevents similar studies by Amanda Feilding Click here for original Article in The Guardian I was amused by Conal Urquhart’s description in the Observer of the novelist Lionel Shriver being sucked into an MRI brain scanner “that resembles a giant washing machine”. I see […]

Continue Reading →

Channel 4 to screen volunteers taking the drug Ecstasy

July 20, 2012 Beckley Science in the Media

An experiment in which volunteers take the dance drug Ecstasy is to be screened on Channel 4 in a first for British television. This research forms part of the Beckley Foundation/Imperial College Psychedelic Research Programme: a collaboration between Amanda Fielding and Prof. David Nutt’s team at Imperial College. July 2012 Click here for original article […]

Continue Reading →

Press Release: The Beckley Foundation-Imperial College Psychedelic Research Programme

January 26, 2012 Beckley Science in the Media

Press Release 25th January 2012 The Beckley Foundation-Imperial College Psychedelic Research Programme Surprising findings of Research: Potential therapeutic applications of psychedelic drugs fMRI brain scans show that psilocybin, the active ingredient in magic mushrooms, lowers the activity of specific brain regions. The finding contradicts the popular belief that psychedelic drugs increase brain activity, and has […]

Continue Reading →

MDMA for treating post traumatic stress disorder: 80% success rate. Beckley Foundation’s work on psilocybin also praised

July 8, 2011 Beckley Science in the Media

An article posted by Craig K. Comstock on the Huffington Post talks of the huge success of Michael Mithoefer’s study into the medicinal purposes of MDMA, in particular reference to treating post traumatic stress disorder (PTSD). After MDMA-assisted psychotherapy, 80% no longer met the diagnostic criteria for PTSD, as compared to only 25% in the […]

Continue Reading →

Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology.

January 19, 2011 Beckley Science in the Media

Authors: Bhattacharyya S, Morrison PD, Fusar-Poli P, Martin-Santos R, Borgwardt S, Winton-Brown T, Nosarti C, O’ Carroll CM, Seal M, Allen P, Mehta MA, Stone JM, Tunstall N, Giampietro V, Kapur S, Murray RM, Zuardi AW, Crippa JA, Atakan Z, McGuire PK. Neuropsychopharmacology. 2010 Feb;35(3):764-74. Abstract Delta-9-tetrahydrocannabinol (Delta-9-THC) and Cannabidiol (CBD), the two main ingredients […]

Continue Reading →

Does intravenous {Delta}9-tetrahydrocannabinol increase dopamine release? A SPET study.

January 19, 2011 Beckley Science in the Media

Authors: Barkus E, Morrison PD, Vuletic D, Dickson J, Ell PJ, Pilowsky LS, Brenneisen R, Holt DW, Powell J, Kapur S, Murray RM. J Psychopharmacol. 2010 Sep 17. [Epub ahead of print] Abstract Intravenous (IV) Δ9-tetrahydrocannabinol (THC) induces transient psychotic symptoms in healthy subjects and in schizophrenic patients, but the psychotomimetic mechanism is unknown. One […]

Continue Reading →

Disruption of Frontal Theta Coherence by Δ(9)-Tetrahydrocannabinol is Associated with Positive Psychotic Symptoms.

January 19, 2011 Beckley Science in the Media

Authors: Morrison PD, Nottage J, Stone JM, Bhattacharyya S, Tunstall N, Brenneisen R, Holt D, Wilson D, Sumich A, McGuire P, Murray RM, Kapur S, Ffytche DH. The Biomedical Research Centre, Institute of Psychiatry, King’s College London, Denmark Hill, UK. Neuropsychopharmacology. 2010 Dec 8 Abstract The main ingredient in cannabis, Δ(9)-tetrahydrocannabinol (THC), can elicit acute […]

Continue Reading →

The administration of psilocybin to healthy hallucinogen-experienced volunteers in a mock-fMRI environment: a preliminary investigation of tolerability

January 19, 2011 Beckley Science in the Media

Authors: Carhart-Harris RL¹², Williams TM², Sessa B², Tyacke RJ¹², Rich AS², Feilding A³, Nutt DJ¹² ¹ Imperial College London, Dept of Neuropsychopharmacology ² University of Bristol, Psychopharmacology Unit ³ The Beckley Foundation ²Corresponding author: r.carhart-harris@imperial.ac.uk Abstract: This study sought to assess the tolerability of intravenously administered psilocybin in healthy, hallucinogen-experienced volunteers in a mock-magnetic resonance […]

Continue Reading →

Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study

January 19, 2011 Beckley Science in the Media

Celia J. A. Morgan, PhD, Gráinne Schafer, BSc, Tom P. Freeman, BSc and H. Valerie Curran, PhD Clinical Psychopharmacology Unit, University College London, London, UK Correspondence: Correspondence: H. Valerie Curran, Clinical Psychopharmacology Unit, Clinical Health Psychology, University College London, Gower St, London WC1E 6BT, UK. Email: v.curran@ucl.ac.uk Background The two main constituents of cannabis, cannabidiol […]

Continue Reading →

Delta-9-tetrahydrocannabinol disruption of time perception and of self-timed actions.

January 19, 2011 Beckley Science in the Media

Delta-9-tetrahydrocannabinol disruption of time perception and of self-timed actions. Stone JM, Morrison PD, Nottage J, Bhattacharyya S, Feilding A, McGuire PK. Pharmacopsychiatry. 2010 Aug;43(6):236-7.

Continue Reading →
Thumbnail image for Amanda Talks about Albert Hofmann on PRI’s The World

Amanda Talks about Albert Hofmann on PRI’s The World

November 23, 2010 Beckley in the Media
Continue Reading →

Slow-Wave Oscillations in the Craniosacral Space: A Hemoliquorodynamic Concept of Origination

November 9, 2010 Beckley Science in the Media

The mechanism of formation of rhythmic, slow-wave oscillations in the craniospinal cavity were studied. Synchronous bioimpedance traces were made of the head and lumbosacral part of the spine in five healthy young subjects at rest and during voluntary breath-holding; these reflect changes in the ratios of blood and CSF volumes in these parts of the […]

Continue Reading →

Age Related Peculiarities of Ratio of Parameters of Functioning of Hemo and Liquorodynamics Systems

November 5, 2010 Beckley Science in the Media

Abstract—For the last decade, owing to methods of computerized neuroradiology, it has been established that the process of the human organism natural aging is accompanied by a gradual atrophic reduction of the brain tissue volume and a decrease of the cerebral blood flow level, while the intracranial cerebrospinal fluid volume increases. The goal of the […]

Continue Reading →

Does intravenous 9-tetrahydrocannabinol increase dopamine release? A SPET study

November 5, 2010 Beckley Science in the Media

ABSTRACT Intravenous (IV) _9-tetrahydrocannabinol (THC) induces transient psychotic symptoms in healthy subjects and in schizophrenic patients, but the psychotomimetic mechanism is unknown. One possibility is that THC stimulates dopamine (DA) release in the striatum. In this study we tested whether IV THC led to an increase in striatal DA release compared to placebo. We also […]

Continue Reading →

Opposite Effects of D-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology

November 5, 2010 Beckley Science in the Media

ABSTRACT: In healthy individuals, D-9-tetrahydrocannabinol (D-9- THC), the main psychoactive ingredient of the Cannabis sativa plant, can induce psychotic symptoms and anxiety, and can impair memory (D’Souza et al, 2004) and psychomotor control (McDonald et al, 2003; Ramaekers et al, 2006). In patients with schizophrenia, D-9-THC may exacerbate existing psychotic symptoms, anxiety and memory impairments […]

Continue Reading →

Plasticity Changes in the Brain in Hypnosis and Meditation

November 4, 2010 Beckley Science in the Media

PLASTICITY CHANGES IN THE BRAIN IN HYPNOSIS AND MEDITATION FULL DOC: http://www.beckleyfoundation.org/bib/doc/bf/2009_Ulrike_211569_1.pdf Abstract Neuroscientific evidence interprets both hypnotic trance induction and different meditation traditions as modified states of consciousness that emphasize attention, concentration and the letting go of thoughts, but they differ in terms of sensory input, processing, memory, and the sense of time. Furthermore, […]

Continue Reading →

It’s the Lack of Balance in Cannabis that Does the Harm

October 21, 2010 Beckley Science in the Media

The effects of cannabis on mental health have attracted much attention over the years. As far back as the 19th century it was recognised that cannabis could induce a transient psychosis which mimics the symptoms of schizophrenia. Despite this, until the last decade or so, most psychiatrists regarded cannabis as essentially benign. This, however, is […]

Continue Reading →

Charity pushes for LSD use in medicine

October 16, 2010 Beckley in the Media

By: Andrew Jack Financial Times Published: February 12 2010 The Financial Times, a prominent business newspaper out of London, UK, published this report about the medical uses of LSD. The article chronicles psychedelic research science being advanced by The Beckley Foundation of the UK. Among LSD research mentioned are the one Swiss and two U.S. […]

Continue Reading →

Key Ingredient Staves off Marijuana Memory Loss

October 4, 2010 Beckley Science in the Media

Cannabis Composition Determines Effects on the Brain. by Arran Frood Some forms of cannabis may contain an ingredient that helps to diminish the drug’s negative effects on memory. Smoking cannabis has long been associated with poor short-term memory, but a study now suggests that the strain of cannabis makes all the difference. In a test […]

Continue Reading →